Brief: Dimerix Records FY Loss Attributable A$10.5 Mln
29/08/2022 04:50
Aug 29 (Reuters) - Dimerix Ltd DXB.AX :
* FY LOSS ATTRIBUTABLE UP 65% TO A$10.5 MILLION
* FY LOSS ATTRIBUTABLE A$10.5 MILLION VERSUS LOSS A$6.4
MILLION
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions